Clinical Trials Browser

Interventional × Synovitis, Pigmented Villonodular × 1 year × Clear all

NCT05804045 2026-05-04

Study of Pimicotinib (ABSK021) for Tenosynovial Giant Cell Tumor (MANEUVER)

Phase 3 Active not recruiting

94 enrolled 16 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT07503821 2026-03-31

SYVIPRO

Phase NA Not yet recruiting

Synovitis, Pigmented Villonodular

NCT05059262 2026-03-20

MOTION

Phase 3 Active not recruiting

123 enrolled 19 charts 1 FDA

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT04703322 2026-03-04

A Study of Pexidartinib in Tenosynovial Giant Cell Tumor in Japan

Phase 2 Active not recruiting

9 enrolled 10 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT01207492 2026-02-20

Nilotinib in Patients With Relapsed or Metastatic Pigmented Villonodular Synovitis/Tenosynovial Giant Cell Tumor/Diffuse-Type Giant Cell Tumor

Phase 2 Completed

17 enrolled 8 charts

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular

NCT05417789 2026-02-02

TANGENT

Phase 3 Active not recruiting

Synovitis, Synovitis, Pigmented Villonodular

NCT03069469 2025-12-18

Study of Vimseltinib (DCC-3014) in Patients With Advanced Tumors and Tenosynovial Giant Cell Tumor

Phase 1/2 Active not recruiting

Giant Cell Tumor of Tendon Sheath, Synovitis, Pigmented Villonodular